Home Amines 992-21-2
992-21-2,MFCD01716199
Catalog No.:AA01CC3K

992-21-2 | L-Lysine,N6-[[[[(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenyl]carbonyl]amino]methyl]-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
25mg
95%
1 week  
$433.00   $303.00
- +
50mg
95%
1 week  
$663.00   $464.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA01CC3K
Chemical Name:
L-Lysine,N6-[[[[(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenyl]carbonyl]amino]methyl]-
CAS Number:
992-21-2
Molecular Formula:
C29H38N4O10
Molecular Weight:
602.6328
MDL Number:
MFCD01716199
SMILES:
N[C@H](C(=O)O)CCCCNCNC(=O)C1=C(O)[C@@]2([C@H]([C@@H](C1=O)N(C)C)C[C@H]1C(=C(O)c3c([C@@]1(C)O)cccc3O)C2=O)O
Properties
Computed Properties
 
Complexity:
1230  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
6  
Heavy Atom Count:
43  
Hydrogen Bond Acceptor Count:
13  
Hydrogen Bond Donor Count:
9  
Rotatable Bond Count:
10  
XLogP3:
-4.4  

Literature

Title: Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.

Journal: The British journal of dermatology 20110801

Title: Gotu Kola induced hepatotoxicity in a child - need for caution with alternative remedies.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20110601

Title: A case of epithelioid angiosarcoma of the scalp treated with paclitaxel and radiotherapy.

Journal: Archives of dermatology 20110101

Title: Acne vulgaris.

Journal: BMJ clinical evidence 20110101

Title: The use of lymecycline and benzoyl peroxide for the treatment of progressive macular hypomelanosis: a prospective study.

Journal: Anais brasileiros de dermatologia 20110101

Title: [Stevens-Johnson syndrome due to lymecycline].

Journal: Annales de dermatologie et de venereologie 20070501

Title: Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline.

Journal: European journal of dermatology : EJD 20070101

Title: Successful treatment of Melkersson-Rosenthal Syndrome with lymecycline.

Journal: European journal of dermatology : EJD 20040101

Title: Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle.

Journal: Journal of the American Academy of Dermatology 20030901

Title: Antibiotic treatment and long term prognosis of reactive arthritis.

Journal: Annals of the rheumatic diseases 20030701

Title: The use of lymecycline in the treatment of moderate to severe acne vulgaris: a comparison of the efficacy and safety of two dosing regimens.

Journal: European journal of dermatology : EJD 20030101

Title: Lymecycline in the treatment of acne: an efficacious, safe and cost-effective alternative to minocycline.

Journal: European journal of dermatology : EJD 20030101

Title: Lymecycline and minocycline in inflammatory acne: a randomized, double-blind intent-to-treat study on clinical and in vivo antibacterial efficacy.

Journal: Skin pharmacology and applied skin physiology 20020101

Title: Systemic antibiotics for acne.

Journal: Dermatology (Basel, Switzerland) 19980101

Title: Combination treatment with ranitidine is highly efficient against Helicobacter pylori despite negative impact of macrolide resistance.

Journal: Helicobacter 19971201

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:992-21-2 Molecular Formula|992-21-2 MDL|992-21-2 SMILES|992-21-2 L-Lysine,N6-[[[[(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenyl]carbonyl]amino]methyl]-